Rendering

Component: (Network and Table)
Network
0004 - Statement - Statements of Operations
(http://accelr8.com/role/StatementsOfOperations)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000727207 (http://www.sec.gov/CIK)
Income Statement [Abstract]Period [Axis]
2011-08-01 - 2012-07-31
2010-08-01 - 2011-07-31
Income Statement [Abstract]
 
 
Revenues:
 
 
Technical development fees
140,000  
842,408  
OptiChem revenue
45,910  
34,279  
License fees
50,000  
xsi:nil 
Qualified discovery therapeutic grant
xsi:nil 
244,479  
Total revenues
235,910  
 
1,121,166  
 
Costs and expenses:
 
 
Research and development
431,906  
454,997  
General and administrative
2,945,309  
810,078  
Amortization
203,460  
253,499  
Depreciation
2,097  
2,396  
Marketing and sales
8,315  
9,621  
Other expense, impairment of intangibles
1,996,583  
xsi:nil 
Total costs and expenses
5,587,670  
 
1,530,591  
 
Income (Loss) from operations
(5,351,760) 
 
(409,425) 
 
Other (expense) income:
 
 
Interest and dividend income
16,297  
16,092  
Unrealized holding gain (loss) on investments
23,987  
14,572  
Unrealized holding gain (loss) on asset sale
1,000  
xsi:nil 
Total other income
41,284  
 
30,664  
 
Net income (loss)
(5,310,476) 
(378,761) 
Net income (loss) per share:
 
 
Basic and diluted net income (loss) per share
(0.43) 
(0.04) 
Weighted average shares outstanding
12,430,060  
10,791,597